<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34292135</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada.</ArticleTitle>
        <Pagination>
          <StartPage>1870909</StartPage>
          <MedlinePgn>1870909</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">1870909</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1870909</ELocationID>
        <Abstract>
          <AbstractText>Between 18 Dec 2017 and 27 June 2018, a mumps outbreak occurred in two Canadian Indigenous communities. An outbreak dose of mumps-containing vaccine was offered as part of control measures. We conducted a cohort study and survival analysis to describe the outbreak and evaluate the outbreak dose, extracting vaccination information on all community members (n = 3,135) from vaccination records. There were 70 mumps cases; 56% had received two pre-outbreak vaccine doses. Those who received a pre-outbreak dose more distantly had higher rates of mumps compared to those with more recent doses (adjusted hazard ratio = 3.4 (95%CI: 0.7-20.6) for receipt &gt;20 years before vs. receipt ≤3 years). During the outbreak, 33% (1,010/3,080) of eligible individuals received an outbreak dose. The adjusted hazard ratio for no outbreak dose receipt was 2.7 (95%CI: 1.0-10.1). Our results suggest that an outbreak dose of mumps-containing vaccine may be an effective public health intervention, but further study is warranted.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rudnick</LastName>
            <ForeName>Wallis</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0003-3457-4216</Identifier>
            <AffiliationInfo>
              <Affiliation>Canadian Field Epidemiology Program, Public Health Agency of Canada, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilson</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-8239-0094</Identifier>
            <AffiliationInfo>
              <Affiliation>Public Health Ontario, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Majerovich</LastName>
            <ForeName>Jo Ann</ForeName>
            <Initials>JA</Initials>
            <Identifier Source="ORCID">0000-0002-4214-0904</Identifier>
            <AffiliationInfo>
              <Affiliation>First Nations and Inuit Health - Ontario Region, Indigenous Services Canada, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haavaldsrud</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>First Nations and Inuit Health - Ontario Region, Indigenous Services Canada, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gatali</LastName>
            <ForeName>Marene</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>First Nations and Inuit Health - Ontario Region, Indigenous Services Canada, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsumoto</LastName>
            <ForeName>Cai-Lei</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Sioux Lookout First Nations Health Authority, Sioux Lookout, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deeks</LastName>
            <ForeName>Shelley</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-4055-1398</Identifier>
            <AffiliationInfo>
              <Affiliation>Public Health Ontario, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008457" MajorTopicYN="Y">Measles</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009107" MajorTopicYN="Y">Mumps</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Mumps</Keyword>
        <Keyword MajorTopicYN="Y">immunization</Keyword>
        <Keyword MajorTopicYN="Y">measles-Mumps-Rubella Vaccine</Keyword>
        <Keyword MajorTopicYN="Y">outbreak dose</Keyword>
        <Keyword MajorTopicYN="Y">vaccine Effectiveness</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>22</Day>
          <Hour>12</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34292135</ArticleId>
        <ArticleId IdType="pmc">PMC8920173</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2020.1870909</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Public Health Agency of Canada . Canadian immunization guide: part 4 - active vaccines – mumps. Mumps Vaccine [Internet]. 2018.  [accessed 2019 Mar
22]. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-14-mumps-vaccine.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Public Health Agency of Canada . Health professionals: mumps [Internet]. 2014.  [accessed 2018 Oct
29]. https://www.canada.ca/en/public-health/services/immunization/vaccine-preventable-diseases/mumps/health-professionals.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention . Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington (DC); Public Health Foundation: 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Barskey AE, Glasser JW, LeBaron CW.. 
Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27(44):6186–8. doi:10.1016/j.vaccine.2009.06.109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2009.06.109</ArticleId>
            <ArticleId IdType="pubmed">19815120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20. doi:10.1503/cmaj.101371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1503/cmaj.101371</ArticleId>
            <ArticleId IdType="pmc">PMC3114893</ArticleId>
            <ArticleId IdType="pubmed">21576295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12–17. doi:10.3201/eid1301.060649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1301.060649</ArticleId>
            <ArticleId IdType="pmc">PMC2913658</ArticleId>
            <ArticleId IdType="pubmed">17370510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marin M, Marlow M, Moore KL, Patel M. Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus–containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep. 2018;67(1):33–38. doi:10.15585/mmwr.mm6701a7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm6701a7</ArticleId>
            <ArticleId IdType="pmc">PMC5769794</ArticleId>
            <ArticleId IdType="pubmed">29324728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatchette TF, Davidson R, Clay S, Pettipas J, Leblanc J, Sarwal S, Smieja M, Forward KR. Laboratory diagnosis of mumps in a partially immunized population: the Nova Scotia experience. Can J Infect Dis Med Microbiol. 2009;20(4):157–62. doi:10.1155/2009/493275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2009/493275</ArticleId>
            <ArticleId IdType="pmc">PMC2807259</ArticleId>
            <ArticleId IdType="pubmed">21119794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Advisory Committee on Immunization; An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) . Statement on mumps vaccine. Can Commun Dis Rep. 2007. 
Aug;33:1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17847161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Ontario . Mumps: epidemiological summary for Ontario [Internet]. 2017.  [accessed 2019 Mar
22]. p. 1–2. https://www.publichealthontario.ca/en/eRepository/Mumps_Ontario_epi_summary.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Baydack R, Rusk R.. 
Updates to health care providers UPDATE: re: mumps reporting and case investigation, Feb. 2, 2017. Manitoba Health - Seniors and Active Living [Internet]. 2017 [accessed 2019 Mar 22]. https://www.gov.mb.ca/health/publichealth/cdc/docs/hcp/2017/020217.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>National Advisory Committee on Immunization, Public Health Agency of Canada . Canadian immunization guide, evergreen edition [Internet] 2017 [accessed 2019 Mar 22]. http://www.phac-aspc.gc.ca/publicat/cig-gci/index-eng.php#toc.</Citation>
        </Reference>
        <Reference>
          <Citation>Trotz-Williams L, Mercer N, Paphitis K, Walters J, Wallace D, Kristjanson E, Gubbay J, Mazzulli T. Challenges in interpretation of diagnostic test results in a mumps outbreak in a highly vaccinated population. Clin Vaccine Immunol. 2017;24(2):e00542. doi:10.1128/CVI.00542-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00542-16</ArticleId>
            <ArticleId IdType="pmc">PMC5299122</ArticleId>
            <ArticleId IdType="pubmed">28003216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walkty A, Van Caeseele P, Hilderman T, Buchan S, Weiss E, Sloane M, Fatoye B. Mumps in prison: description of an outbreak in Manitoba, Canada. Can J Public Health. 2011;102(5):341–44. doi:10.1007/BF03404173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03404173</ArticleId>
            <ArticleId IdType="pmc">PMC6974286</ArticleId>
            <ArticleId IdType="pubmed">22032098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philadelphia Department of Public Health . Update: mumps outbreak at a university in Philadelphia. Health Alert Network [Internet]. 2019.  [accessed Mar
25 2019]. https://www.health.pa.gov/topics/Documents/HAN/2019-PAHAN-437-03-02-ADV-Mumps.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Dubey V, Ozaldin O, Shulman L, Stuart R, Maclachlan J, Bromley L, Summers A. Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017–February 2018. Can Commun Dis Rep. 2018.  Dec;44:309–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6707419</ArticleId>
            <ArticleId IdType="pubmed">31517953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parker Fiebelkorn A, Lawler J, Curns AT, Brandeburg C, Wallace GS. Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA. Emerg Infect Dis. 2013;19(9):1411–17. doi:10.3201/eid1909.130299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1909.130299</ArticleId>
            <ArticleId IdType="pmc">PMC3810923</ArticleId>
            <ArticleId IdType="pubmed">23965729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, Quinlisk P. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med. 2017;377(10):947–56. doi:10.1056/NEJMoa1703309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1703309</ArticleId>
            <ArticleId IdType="pmc">PMC6546095</ArticleId>
            <ArticleId IdType="pubmed">28877026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vygen S, Fischer A, Meurice L, Mounchetrou Njoya I, Gregoris M, Ndiaye B, Ghenassia A, Poujol I, Stahl JP, Antona D, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Eurosurveillance. 2016;21(10):1–8. doi:10.2807/1560-7917.ES.2016.21.10.30156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.10.30156</ArticleId>
            <ArticleId IdType="pubmed">26987576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamami D, Cameron R, Pollock KG, Shankland C. Waning immunity is associated with periodic large outbreaks of mumps: a mathematical modeling study of Scottish data. Front Physiol. 2017;8:(APR):1–11. doi:10.3389/fphys.2017.00233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2017.00233</ArticleId>
            <ArticleId IdType="pmc">PMC5404202</ArticleId>
            <ArticleId IdType="pubmed">28487657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546–50. doi:10.1007/s11606-010-1609-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11606-010-1609-1</ArticleId>
            <ArticleId IdType="pmc">PMC3077477</ArticleId>
            <ArticleId IdType="pubmed">21203857</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
